Commentary on increased risk of biochemical and local failure in patients with a distended rectum on the planning CT for prostate cancer radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 4, 2005, Pages 949-950

  Roach III, Mack ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BARIUM ENEMA; BIOCHEMISTRY; CANCER CONTROL; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; ERROR; HIGH RISK POPULATION; HUMAN; IMAGING; MORBIDITY; OBESITY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RECTUM DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

BALLOON DILATATION; DILATATION, PATHOLOGIC; FLATULENCE; GASES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; TREATMENT OUTCOME;

EID: 21244488526     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.03.067     Document Type: Editorial

References (12)

1. R. De Crevoisier, S.L. Tucker, L. Dong Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy Int J Radiat Oncol Biol Phys 62 2005 965 973
2. M. Roach, B. Pickett, S. Rosenthal Defining treatment margins for 3-D based six field conformal (SFC) irradiation of localized prostate cancer Int J Radiat Oncol Biol Phys 28 1994 267 275
3. M. Aubin, J. Pouliot, L. Millender Daily prostate targeting with implanted gold markers and an a-Si flat panel EPID at UCSF A five year clinical experience [Abstract] Int J Radiat Oncol Biol Phys 60 Suppl. 1 2004 S266 S267
4. M.V. Pilepich, S.C. Prasad, C.A. Perez Computed tomography in definitive radiotherapy of prostatic carcinoma, Part 2 Definition of target volume Int J Radiat Oncol Biol Phys 8 1982 235 240
5. M.A. Bagshaw, R.S. Cox, G.R. Ray Status of prostate cancer at Stanford University NCI Monogr 7 1988 47 60
6. C.J. Rossi Jr, J.D. Slater, N. Reyes-Molyneux Particle beam radiation therapy in prostate cancer Is there an advantage? Semin Radiat Oncol 8 1998 115 123
7. B.S. Teh, S.Y. Woo, W.Y. Mai Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization Med Dosim 27 2002 105 113
8. A.L. Zietman, M. DeSilvio, J.D. Slater A randomized trial comparing conventional dose (70.2 GyE) and high-dose (79.2 GyE) conformal radiation in early stage adenocarcinoma of the prostate. Results of an interim analysis of PROG 95-09 [Abstract] Int J Radiat Oncol Biol Phys 60 Suppl. 1 2004 S131 S132
9. A. Pollack, G.K. Zagars, L.G. Smith Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer J Clin Oncol 18 2000 3904 3911
10. L.E. Millender, M. Aubin, J. Pouliot Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 6 10
11. S. Malone, J.M. Crook, W.S. Kendal Respiratory-induced prostate motion Quantification and characterization Int J Radiat Oncol Biol Phys 48 2000 105 109
12. W.R. Lee, M. Roach III, J. Michalski Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy Int J Radiat Oncol Biol Phys 54 2002 457 461